Public
American Hospital Association content that is available to the public and all website users.
The FBI first became aware of RagnarLocker in April 2020 and subsequently produced a FLASH to disseminate known indicators of compromise (IOCs) at that time. This FLASH provides updated and additional IOCs to supplement that report.
Responding to a request for information on digital health, the AHA March 4th urged Congress to permanently eliminate all restrictions on telehealth originating and geographic sites; continue to allow rural health clinics and federally qualified health centers to serve as distant sites for all…
: Letter with comments to CMS on the burden estimates associated with the delivery of good faith estimates to uninsured and self-pay patients and the patient-provider dispute resolution process established under the No Surprises Act.
Finished Intelligence report regarding weekly threat brief from the HHS Health Sector Cybersecurity Coordination Center (HC3).
HC3 TLP White Report: Health Sector Cybersecurity: 2021 Retrospective and 2022 Look Ahead – March 3, 2022
Cybersecurity Report: FBI & AHA discuss Russia, Ukraine and Cybersecurity in U.S. Health Care Sector
John Riggi, who spent nearly 30 years as a highly decorated veteran of the FBI and now serves as National Advisor for Cybersecurity and Risk at the American Hospital Association and their 5000+ member hospitals. In his role, he serves as a national resource to assist members in defending against…
This document was developed in furtherance of NSA’s cybersecurity missions.
The Snapshot is the American Hospital Association’s look at America’s hospitals’ capacity to provide care during COVID-19. America’s hospitals and health systems continue to face historic challenges, including unprecedented financial pressures. It is vitally important that hospitals and health…
The United States National Security Agency (NSA) has released a new Cybersecurity Technical Report (CTR): Network Infrastructure Security Guidance.
AHA urges HHS to ensure hospitals participating in the 340B Drug Pricing Program do not lose access to the program as a result of changes in patterns of patient care due to the COVID-19 public health emergency (PHE).